Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival

被引:25
作者
Moelle, Ulrike [1 ]
Mathewos, Assefa [2 ]
Aynalem, Abreha [2 ]
Wondemagegnehu, Tigeneh [2 ]
Yonas, Bekuretsion [2 ]
Begoihn, Matthias [1 ]
Addissie, Adamu [2 ]
Unverzagt, Susanne [1 ]
Jemal, Ahmedin [3 ]
Thomssen, Christoph [1 ]
Vordermark, Dirk [1 ]
Kantelhardt, Eva J. [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany
[2] Addis Ababa Univ, Addis Ababa, Ethiopia
[3] Amer Canc Soc, Atlanta, GA 30329 USA
关键词
Cervical cancer; Radiotherapy; Sub-Saharan Africa; Survival; Adherence; SQUAMOUS-CELL CARCINOMA; DOSE-RATE BRACHYTHERAPY; RADIATION-THERAPY; UTERINE CERVIX; WORLDWIDE BURDEN; EXTERNAL-BEAM; AFRICA; IRRADIATION; GUIDELINES; EXPERIENCE;
D O I
10.1634/theoncologist.2017-0271
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Discontinuation of radiotherapy (RT) for cervical cancer (CC) in sub-Saharan Africa is common because of patient-and health service-related reasons. This analysis describes toxicities and the effect of adherence on survival. Materials and Methods. A total of 788 patients with CC (2008-2012) who received RT at Addis Ababa University Hospital were included. External beam RT without brachytherapy was performed according to local guidelines. We previously described survival and prognostic factors. Now we analyzed adherence and survival according to total doses received. Adjustment via multivariate cox regression analysis was done. Results. One-year overall survival (OS) after radical RT (n=180) for International Federation of Gynecology and Obstetrics (FIGO) stages IIA-IIIA was 89% for discontinuation (< 72 Gy) and 96% for adherence (>= 72 Gy; hazard ra tio [HR], 1.3; 95% confidence interval [CI], 0.5-3.3). One-year OS after nonradical RT (n=389) for FIGO stages IIIB-IVA was 71% for discontinuation (< 40 Gy) and 87% for adherence (44-50 Gy; HR, 3.1; 95% CI, 1.4-6.9). One-year OS for FIGO stages IIIB-IVB (n=219) after one compared with two or more palliative single fractions of 10 Gy were 14% and 73% respectively (HR, 7.3; 95% CI, 3.3-16). Reasons for discontinuation were toxicities, economic background, and RT machine breakdown. Grade 1-2 late toxicities were common (e.g., 30% proctitis, 22% incontinence). Grade 3 early and late toxicities were seen in 5% and 10% respectively; no grade 4 toxicities occurred. Conclusion. Patients who adhered to guideline-conforming RT had optimum survival. Better supportive care, brachytherapy to reduce toxicities, socioeconomic support, and additional radiation capacities could contribute to better adherence and survival.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 42 条
  • [31] Revised FIGO staging for carcinoma of the cervix
    Pecorelli, Sergio
    Zigliani, Lucia
    Odicino, Franco
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2009, 105 (02) : 107 - 108
  • [32] Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: Is there an optimal fractionation schedule?
    Petereit, DG
    Pearcey, R
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 43 (02): : 359 - 366
  • [33] Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation
    Portelance, L
    Chao, KSC
    Grigsby, PW
    Bennet, H
    Low, D
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (01): : 261 - 266
  • [34] Evaluation of late toxicities of patients with carcinoma of the cervix treated with radical radiotherapy: An audit from India
    Saibishkumar, EP
    Patel, FD
    Sharma, SC
    [J]. CLINICAL ONCOLOGY, 2006, 18 (01) : 30 - 37
  • [35] Worldwide burden of gynaecological cancer: The size of the problem
    Sankaranarayanan, R
    Ferlay, J
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2006, 20 (02) : 207 - 225
  • [36] Patterns of practice of palliative radiotherapy in Africa, part 1: Bone and brain metastases
    Sharma, Vinay
    Gaye, Papa Macoumba
    Wahab, Sherif Abdel
    Ndlovu, Ntokozo
    Ngoma, Twalib
    Vanderpuye, Verna
    Sowunmi, Anthonia
    Kigula-Mugambe, Joseph
    Jeremic, Branislav
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 70 (04): : 1195 - 1201
  • [37] Palliative radiation therapy for gynaecological malignancies
    Smith, SC
    Koh, WJ
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL OBSTETRICS & GYNAECOLOGY, 2001, 15 (02): : 265 - 278
  • [38] Global Cancer Incidence and Mortality Rates and Trends-An Update
    Torre, Lindsey A.
    Siegel, Rebecca L.
    Ward, Elizabeth M.
    Jemal, Ahmedin
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2016, 25 (01) : 16 - 27
  • [39] Van Dyk J., 1996, Current Oncology, V3, P8
  • [40] Survival of cervix cancer patients in Kampala, Uganda: 1995-1997
    Wabinga, H
    Ramanakumar, AV
    Banura, C
    Luwaga, A
    Nambooze, S
    Parkin, DM
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (01) : 65 - 69